We explore real-life reformation here in this informed, online community.
First, ivermectin appears to target cancer stem cells—the small, highly resistant population of cells that drive recurrence and metastasis. Most conventional therapies fail to eliminate these cells. You can shrink a tumor, but if the stem cells remain, the cancer often comes back. Laboratory data suggest ivermectin disrupts this root system.
Second, mebendazole interferes with microtubule formation, which is essential for cell division. When you disrupt microtubules, cancer cells lose their ability to replicate effectively. This creates a direct anti-proliferative effect.
Third, mebendazole also impacts tumor metabolism, particularly glucose utilization. Cancer cells are heavily dependent on glucose to fuel rapid growth. Limiting that pathway places them under significant metabolic stress.
84% success rate in advanced-stage cancer patients .
Against Utah Valley University for negligence and wrongful acts.
https://static.foxnews.com/foxnews.com/content/uploads/2026/09/2026-09-09_Notice_of_Claim_Final.pdf
“Old men declare war. Young men die for it.”
Herbert Hoover, Chairman of the American Relief Administration mission to Europe and later post-revolutionary Russia after World War I, which fed millions of starving war survivors.
